Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PM | -15.32% | $285.56B | +81.21% | 2.90% |
HIHO | -14.95% | $7.70M | -15.05% | 4.14% |
CIG.C | -12.41% | $2.62B | +24.05% | 0.00% |
CBOE | -11.79% | $23.60B | +33.06% | 1.12% |
KO | -9.54% | $299.66B | +11.16% | 2.85% |
HUSA | -9.44% | $31.37M | +61.29% | 0.00% |
FMTO | -9.21% | $4.80K | -99.93% | 0.00% |
ED | -8.67% | $36.52B | +12.13% | 3.30% |
MO | -7.45% | $99.37B | +31.67% | 6.86% |
EXC | -7.35% | $42.79B | +21.50% | 3.68% |
LITB | -7.20% | $22.07M | -76.50% | 0.00% |
DUK | -6.34% | $89.22B | +14.76% | 3.64% |
CME | -6.31% | $97.19B | +37.23% | 3.92% |
AMT | -6.27% | $100.72B | +11.60% | 3.10% |
VSTA | -5.53% | $341.26M | +39.51% | 0.00% |
AWK | -5.40% | $27.48B | +8.01% | 2.22% |
AEP | -5.40% | $54.28B | +16.07% | 3.62% |
K | -4.84% | $27.83B | +36.45% | 2.85% |
CL | -4.79% | $71.83B | -8.64% | 2.30% |
NNN | -4.35% | $7.97B | +0.47% | 5.46% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DFDV | 0.08% | $458.02M | +2,978.39% | 0.00% |
AQB | 0.10% | $2.92M | -54.87% | 0.00% |
PG | 0.17% | $371.66B | -5.96% | 2.57% |
WEC | 0.20% | $33.22B | +33.38% | 3.32% |
BTI | 0.27% | $106.86B | +56.75% | 6.20% |
TU | -0.30% | $24.32B | +2.44% | 7.20% |
MSIF | -0.31% | $820.39M | +45.09% | 6.03% |
FTS | -0.38% | $23.77B | +23.16% | 3.69% |
KDP | -0.50% | $44.64B | -4.70% | 2.75% |
EDU | -0.66% | $7.75B | -34.42% | 0.00% |
EVRG | -0.69% | $15.36B | +26.40% | 3.98% |
VIV | -0.73% | $17.64B | +38.62% | 0.00% |
EQX | 1.07% | $2.89B | +18.73% | 0.00% |
PSQH | -1.34% | $95.63M | -32.48% | 0.00% |
BULL | 1.46% | $4.79B | -6.65% | 0.00% |
T | 1.48% | $198.96B | +53.19% | 4.00% |
TKC | 1.63% | $5.13B | -20.33% | 3.50% |
CORT | -1.80% | $7.62B | +155.24% | 0.00% |
PRT | -1.80% | $49.51M | +7.39% | 10.83% |
CYCN | -1.85% | $9.97M | +40.57% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RGNX | 52.27% | $436.37M | -29.07% | 0.00% |
KYMR | 51.64% | $3.02B | +48.56% | 0.00% |
XNCR | 48.19% | $591.43M | -57.25% | 0.00% |
MEDP | 46.98% | $8.56B | -26.07% | 0.00% |
XENE | 46.88% | $2.43B | -12.55% | 0.00% |
IMNM | 46.60% | $778.76M | -32.61% | 0.00% |
DNLI | 45.39% | $2.04B | -32.06% | 0.00% |
RXRX | 44.45% | $1.97B | -50.10% | 0.00% |
GBIO | 44.43% | $25.61M | -85.85% | 0.00% |
IDYA | 44.28% | $1.92B | -41.19% | 0.00% |
IOSP | 43.97% | $2.08B | -32.52% | 1.94% |
SLAB | 43.89% | $4.62B | +19.68% | 0.00% |
RVMD | 43.89% | $7.29B | +3.76% | 0.00% |
IPGP | 43.65% | $2.84B | -19.22% | 0.00% |
EYPT | 42.64% | $606.23M | +1.38% | 0.00% |
CMCO | 42.62% | $426.05M | -57.22% | 1.86% |
KN | 42.57% | $1.47B | -2.70% | 0.00% |
CMC | 42.43% | $5.53B | -3.51% | 1.45% |
IQV | 42.29% | $26.66B | -27.59% | 0.00% |
CMPS | 42.05% | $415.96M | -30.33% | 0.00% |
Yahoo
LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced Alfred W. Sandrock, Jr., M.D., Ph.D., Chief Executive Officer of Voyager, and additional members of management will participate in a pre-recorded fireside chat at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference. An on-demand webcast of the pre-recorded fireside chat will be avail
SeekingAlpha
Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's market. Click here to read more.
Yahoo
After a rocky start to the spring, Wall Street came roaring back in May. President Trump’s softened tariff stance reignited demand for risk assets, triggering the market’s biggest monthly rally since November 2023. The S&P 500 rose ~6%, nudging back into positive territory for the year. Encouraged by this rebound, John Stoltzfus, chief investment strategist at Oppenheimer, has taken the measure of the markets and holds a positive outlook for the near- to mid-term. “The effects of the stock marke
Yahoo
Key Insights Significantly high institutional ownership implies Voyager Therapeutics' stock price is sensitive to their...
Yahoo
LEXINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced the first peer-reviewed publication of data demonstrating the ability of alkaline phosphatase (ALPL) to transport a novel AAV capsid across the blood-brain barrier (BBB). The article, titled “Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-b
Finnhub
Voyager Therapeutics, Inc. announced the first peer-reviewed publication of data demonstrating the ability of alkaline phosphatase to transport a novel AAV capsid across the blood-brain barrier . The...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 56.52% | $4.57B | 0.35% |
IBB | 53.91% | $5.43B | 0.45% |
GNOM | 53.53% | $43.91M | 0.5% |
IWC | 51.95% | $791.26M | 0.6% |
ARKG | 51.16% | $981.47M | 0.75% |
IWO | 50.92% | $11.13B | 0.24% |
IWM | 49.07% | $62.16B | 0.19% |
VTWO | 48.93% | $12.13B | 0.07% |
PBE | 48.87% | $223.42M | 0.58% |
KJAN | 48.64% | $286.04M | 0.79% |
GSSC | 48.15% | $540.71M | 0.2% |
SCHA | 47.69% | $16.74B | 0.04% |
ESML | 46.97% | $1.79B | 0.17% |
BBH | 46.96% | $337.72M | 0.35% |
ISCG | 46.83% | $656.19M | 0.06% |
KOMP | 46.70% | $2.19B | 0.2% |
XPH | 46.63% | $151.38M | 0.35% |
SMMD | 46.44% | $1.40B | 0.15% |
NUSC | 46.41% | $1.11B | 0.31% |
IWN | 46.25% | $10.67B | 0.24% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
OILK | 0.01% | $74.96M | 0.69% |
SMMU | -0.05% | $869.65M | 0.35% |
JPST | 0.05% | $31.56B | 0.18% |
TLT | 0.08% | $48.40B | 0.15% |
IBMS | -0.09% | $80.20M | 0.18% |
CGMU | 0.10% | $3.29B | 0.27% |
IBDR | 0.12% | $3.31B | 0.1% |
BND | -0.13% | $129.18B | 0.03% |
FLCB | 0.16% | $2.56B | 0.15% |
JSI | -0.24% | $834.92M | 0.49% |
TFI | 0.24% | $3.20B | 0.23% |
BSCQ | 0.25% | $4.24B | 0.1% |
CMBS | -0.27% | $440.11M | 0.25% |
DBC | 0.29% | $1.26B | 0.87% |
FMB | -0.29% | $1.90B | 0.65% |
OWNS | 0.30% | $127.16M | 0.3% |
NYF | -0.39% | $887.34M | 0.25% |
STOT | -0.42% | $239.87M | 0.45% |
EDV | 0.46% | $3.38B | 0.05% |
NUBD | 0.47% | $392.86M | 0.16% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -36.41% | $296.94M | 1.43% |
VIXY | -31.49% | $196.95M | 0.85% |
TAIL | -30.75% | $104.04M | 0.59% |
IVOL | -25.36% | $346.82M | 1.02% |
SPTS | -17.93% | $5.79B | 0.03% |
UTWO | -16.47% | $375.05M | 0.15% |
STPZ | -16.09% | $444.20M | 0.2% |
IBTG | -15.97% | $1.95B | 0.07% |
VTIP | -15.74% | $15.13B | 0.03% |
IBTH | -14.75% | $1.58B | 0.07% |
ULST | -14.70% | $667.74M | 0.2% |
XONE | -13.89% | $639.76M | 0.03% |
IBTI | -13.21% | $1.04B | 0.07% |
VGSH | -13.12% | $22.49B | 0.03% |
SCHO | -13.12% | $10.94B | 0.03% |
STIP | -12.97% | $12.60B | 0.03% |
TDTT | -12.67% | $2.60B | 0.18% |
IEI | -12.31% | $15.27B | 0.15% |
IBTJ | -11.70% | $676.83M | 0.07% |
LDUR | -11.60% | $917.07M | 0.5% |
Current Value
$3.111 Year Return
Current Value
$3.111 Year Return